Table 2 Change in Clinical Metrics: Baseline vs. 90 Days
N | Baseline Mean (SD) | 90 Days Mean (SD) | % Change | P-value | |
|---|---|---|---|---|---|
HbA1c (%) | 204 | 8.9 (1.8) | 7.0 (0.9) | −21.2% | < 0.001 |
HOMA2-B | 237 | 55.1 (38.6) | 57.6 (33.3) | 4.5% | 0.37 |
HOMA2-IR | 237 | 2.3 (1.7) | 1.5 (0.8) | −35.3% | < 0.001 |
ALT (u/L) | 239 | 32.5 (17.7) | 30.7 (32.4) | −5.8% | 0.39 |
BMI (kg/m2) | 250 | 28.3 (4.9) | 26.5 (4.6) | −6.3% | < 0.001 |
Weight (kg) | 247 | 78.0 (14.5) | 72.8 (13.3) | −6.7% | < 0.001 |
10-Year ASCVD Risk | 179 | 12.2% (12.2%) | 10.6% (11.0%) | −12.7% | < 0.001 |
eGFR (mL/min/1.73m2) | 239 | 102.2 (18.3) | 104.0 (15.3) | 1.7% | 0.03 |
Total WBC Count (cells/mm3) | 242 | 7764.9 (1746.7) | 7405.7 (1719.9) | −4.6% | < 0.001 |
Testosterone (Male) (ng/dL) | 109 | 396.1 (183.1) | 453.4 (165.4) | 14.5% | < 0.001 |